357 related articles for article (PubMed ID: 12724763)
1. Novel strategies for the treatment of sepsis.
Riedemann NC; Guo RF; Ward PA
Nat Med; 2003 May; 9(5):517-24. PubMed ID: 12724763
[TBL] [Abstract][Full Text] [Related]
2. The enigma of sepsis.
Riedemann NC; Guo RF; Ward PA
J Clin Invest; 2003 Aug; 112(4):460-7. PubMed ID: 12925683
[TBL] [Abstract][Full Text] [Related]
3. Complement-related molecular events in sepsis leading to heart failure.
Hoesel LM; Niederbichler AD; Ward PA
Mol Immunol; 2007 Jan; 44(1-3):95-102. PubMed ID: 16875736
[TBL] [Abstract][Full Text] [Related]
4. The dark side of C5a in sepsis.
Ward PA
Nat Rev Immunol; 2004 Feb; 4(2):133-42. PubMed ID: 15040586
[TBL] [Abstract][Full Text] [Related]
5. [Advances in research of the roles of C5a-C5L2, high mobility group B1 and Toll like receptor 4 in sepsis].
Fang Y; Li C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):155-7. PubMed ID: 25665619
[No Abstract] [Full Text] [Related]
6. Novel complementary peptides to target molecules.
Okada H; Imai M; Ono F; Okada A; Tada T; Mizue Y; Terao K; Okada N
Anticancer Res; 2011 Jul; 31(7):2511-6. PubMed ID: 21873168
[TBL] [Abstract][Full Text] [Related]
7. A key role of C5a/C5aR activation for the development of sepsis.
Riedemann NC; Guo RF; Ward PA
J Leukoc Biol; 2003 Dec; 74(6):966-70. PubMed ID: 12960283
[TBL] [Abstract][Full Text] [Related]
8. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease.
Thrane AS; Skehan JD; Thrane PS
Med Hypotheses; 2007; 68(6):1363-70. PubMed ID: 17169498
[TBL] [Abstract][Full Text] [Related]
9. Synthetic small-molecule complement inhibitors.
Holland MC; Morikis D; Lambris JD
Curr Opin Investig Drugs; 2004 Nov; 5(11):1164-73. PubMed ID: 15573867
[TBL] [Abstract][Full Text] [Related]
10. Experimental therapeutic strategies for severe sepsis: mediators and mechanisms.
Parrish WR; Gallowitsch-Puerta M; Czura CJ; Tracey KJ
Ann N Y Acad Sci; 2008 Nov; 1144():210-36. PubMed ID: 19076379
[TBL] [Abstract][Full Text] [Related]
11. Role of C5a-C5aR interaction in sepsis.
Guo RF; Riedemann NC; Ward PA
Shock; 2004 Jan; 21(1):1-7. PubMed ID: 14676676
[TBL] [Abstract][Full Text] [Related]
12. C5a, interleukin-8 and tumour necrosis factor-alpha-induced changes in granulocyte and monocyte expression of complement receptors in whole blood and on isolated leukocytes.
Furebring M; Håkansson L; Venge P; Sjölin J
Scand J Immunol; 2006 Mar; 63(3):208-16. PubMed ID: 16499574
[TBL] [Abstract][Full Text] [Related]
13. The "cytokine profile": a code for sepsis.
Ulloa L; Tracey KJ
Trends Mol Med; 2005 Feb; 11(2):56-63. PubMed ID: 15694867
[TBL] [Abstract][Full Text] [Related]
14. Effects of L-156,602, a C5a receptor antagonist, on mouse experimental models of inflammation.
Tsuji RF; Magae J; Nagai K; Yamasaki M
Biosci Biotechnol Biochem; 1992 Dec; 56(12):2034-6. PubMed ID: 1369097
[TBL] [Abstract][Full Text] [Related]
15. Drug evaluation: the C5a receptor antagonist PMX-53.
Köhl J
Curr Opin Mol Ther; 2006 Dec; 8(6):529-38. PubMed ID: 17243489
[TBL] [Abstract][Full Text] [Related]
16. Activated protein C: controversy and hope in the treatment of sepsis.
Baillie JK
Curr Opin Investig Drugs; 2007 Nov; 8(11):933-8. PubMed ID: 17979027
[TBL] [Abstract][Full Text] [Related]
17. The role of complement, C5a and its receptors in sepsis and multiorgan dysfunction syndrome.
Flierl MA; Schreiber H; Huber-Lang MS
J Invest Surg; 2006; 19(4):255-65. PubMed ID: 16835140
[TBL] [Abstract][Full Text] [Related]
18. C5a receptor antagonists for the treatment of inflammation.
Sumichika H
Curr Opin Investig Drugs; 2004 May; 5(5):505-10. PubMed ID: 15202723
[TBL] [Abstract][Full Text] [Related]
19. High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease.
Hoshina T; Kusuhara K; Ikeda K; Mizuno Y; Saito M; Hara T
Scand J Rheumatol; 2008; 37(6):445-9. PubMed ID: 18720262
[TBL] [Abstract][Full Text] [Related]
20. [C5A receptor: a new potential therapeutic target for immune-mediated glomerulonephritis].
Cannone M
G Ital Nefrol; 2012; 29(6):645. PubMed ID: 23229657
[No Abstract] [Full Text] [Related]
[Next] [New Search]
